共 50 条
- [11] Aspirin, COX-2, and the risk of colorectal cancer - ReplyNEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (08): : 824 - 825Chan, Andrew T.Ogino, ShujiFuchs, Charles S.
- [12] Glycosylation of cyclooxygenase-2 (COX-2) influences effectiveness of COX-2 inhibitorsFASEB JOURNAL, 2009, 23Graham, Kamara WhitneySevigny, Mary B.Gabriel, Bianca S.
- [13] Will COX-2 inhibitors change pain management?PHYSICIAN AND SPORTSMEDICINE, 1999, 27 (02): : 34 - 35Schnirring, L
- [14] Safety of COX-2 inhibitors in asthma patients with aspirin hypersensitivityANNALS OF PHARMACOTHERAPY, 2003, 37 (10) : 1497 - 1501West, PMFernández, C
- [15] Selective COX-2 inhibitors, NSAIDs, aspirin, myocardial infarctionARCHIVES OF INTERNAL MEDICINE, 2002, 162 (10) : 1091 - 1092Dalen, JE
- [16] COX-2 inhibitors may raise cardiovascular risksPHYSICIAN AND SPORTSMEDICINE, 1999, 27 (03): : 15 - 15不详
- [17] Modeling the impact of patient and clinical heterogeneities on the cost-effectiveness of selective COX-2 inhibitors such as lumiracoxib and conventional NSAIDs in patients with osteoarthritisVALUE IN HEALTH, 2006, 9 (03) : A25 - A26Huels, JWright, AKahler, KOmar, MDubois, RWChiou, CFDoan, QV
- [18] NSAIDs: gastroprotection or selective COX-2 inhibitors? ReplyPALLIATIVE MEDICINE, 2005, 19 (02) : 166 - 167Dickman, AEllershaw, J
- [19] COX-2 inhibitors and risk of heart failure - ReplyLANCET, 2004, 364 (9444): : 1487 - 1487Wardle, EN